Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Global Hemophilia B Gene Therapy Market Report 2026 | Capitalize on 29.8% CAGR as Pfizer, CSL Behring, Bayer, and REGENXBIO Accelerate AAV Innovation
5 High-Yield Dividend Stocks That Could Hold Up When the Market Falls
Pfizer (NYSE:PFE) Stock Rating Lowered by DZ Bank
Buy, Sell, or Hold? Friday's Top Upgrades and Downgrades: Becton Dickinson, BJ's Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More
76,849 Pfizer Inc. $PFE Shares Purchased by Chicago Partners Investment Group LLC
What Is Pfizer (PFE) Signaling With Its Viagra Playbook For Obesity Drugs?
Pfizer (NYSE:PFE) Shares Down 2.9% - Should You Sell?
Stock Traders Buy High Volume of Pfizer Call Options (NYSE:PFE) - Markets Daily
Traders Buy High Volume of Call Options on Pfizer (NYSE:PFE) - Stock Observer
Pfizer (NYSE:PFE) Stock Price Expected to Rise, Guggenheim Analyst Says
Pfizer (NYSE:PFE) Sets New 12-Month High on Analyst Upgrade
Are Your Dividends Safe? 4 Companies Whose Debt Is Competing With the Payout
21,573 Pfizer Inc. $PFE Shares Sold by Kelleher Financial Advisors - Markets Daily
Pfizer Inc. $PFE Stock: Pzena Investment Management LLC Boosts Stake
European Enterprises Face Growing Pressure to Turn AI Investment into Business Value, ISG Says
Pfizer (NYSE:PFE) Given New $33.00 Price Target at Guggenheim - Daily Political
Pfizer Inc. $PFE Shares Newly Acquired by Associated Banc Corp
Pfizer (NYSE:PFE) Reaches New 1-Year High Following Analyst Upgrade - Daily Political
Pfizer (PFE) Q3 Earnings Rebuild Confidence As New Drugs Gain Ground
Cardiac and vascular involvement in protein misfolding diseases
Positional replication fork instability drives PARP inhibitor cytotoxicity
Pfizer (NYSE:PFE) Given New $30.00 Price Target at UBS Group
Scotiabank Forecasts Strong Price Appreciation for Pfizer (NYSE:PFE) Stock
Pfizer (NYSE:PFE) Stock Price Up 2.6% on Strong Earnings
Citigroup Issues Positive Forecast for Pfizer (NYSE:PFE) Stock Price
Pfizer (NYSE:PFE) Stock Price Up 2.6% After Strong Earnings - Stock Observer
Pfizer (NYSE:PFE) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS - Markets Daily
Pfizer Just Raised Guidance. The Bigger Test Comes Next
Pfizer (NYSE:PFE) Price Target Raised to $30.00 - Daily Political
Pfizer Inc. (PFE) to Issue Quarterly Dividend of $0.43 on December 7th - Markets Daily
United Therapeutics Announces Buydown of Ralinepag Royalty
North American Morning Briefing: Stock Futures Higher as Investors Weigh Blue Win | Morningstar
Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - Daily Political
Pfizer Inc. $PFE Shares Newly Acquired by First Nebraska Trust Co
Pfizer Inc. $PFE Shares Sold by AIA Group Ltd
Pfizer Q3 Earnings Call Highlights
Pfizer Inc. $PFE Shares Bought by Rakuten Investment Management Inc. - Daily Political
First Nebraska Trust Co Makes New $2.97 Million Investment in Pfizer Inc. $PFE - Daily Political
International Business: Pfizer net profit up
Analysts Offer Insights on Healthcare Companies: Amplia Therapeutics (OtherINNMF), Pfizer (PFE) and BioMarin Pharmaceutical (BMRN)
Health Care Down on Fears of New Regulation - Health Care Roundup | Morningstar
Pfizer Inc. Q3 2026 Earnings Call Summary
Pfizer (NYSE:PFE) Shares Down 2.3% - Here's What Happened
Dow Jones Top Company Headlines at 3 PM ET: Google Curbs AI in School Accounts After Pushback | Pfizer ... | Morningstar
Pfizer Lifts FY26 Guidance; Reports Strong Growth Across Multiple Products
Pfizer (NYSE: PFE) raises revenue guidance by $1.5 billion, but the quarter is flat - Markets Daily
Pfizer Earnings: Our Pipeline View Is Incrementally Positive | Morningstar
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Pfizer Earnings: Our Pipeline View Is Incrementally Positive; Maintaining Fair Value Estimate | Morningstar
Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market
Pfizer earnings analysis: questions answered and next catalysts
Dow Jones Top Company Headlines at 1 PM ET: Pfizer Raises Forecast on Momentum With New Products | Foodtastic ... | Morningstar
Stock market today: Dow, S&P 500, Nasdaq waver ahead of midterm election results, AMD earnings
Merck's Pipeline Could Be Its Next Big Growth Driver. Its Latest Earnings Offer a Clue. - 24/7 Wall St.
Pfizer Raises 2026 Outlook and Names New CFO After Earnings Beat
Dow Jones Top Company Headlines at 11 AM ET: Pfizer Raises Forecast on Momentum With New Products | Foodtastic ... | Morningstar
Pfizer promotes insider to CFO
Pfizer (NYSE:PFE) Posts Earnings Results, Beats Expectations By $0.13 EPS
Pfizer (PFE) Reports Q3 Earnings: What Key Metrics Have to Say
Dow Jones Top Company Headlines at 9 AM ET: Pfizer Raises Forecast on Momentum With New Products | Yum ... | Morningstar
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
Pfizer earnings take a tumble as revenue slips in third quarter
Arvinas Inc Reports Q3 2026: EPS of -$0.82 Beats Estimates While
Pfizer Raises Forecast on Momentum With New Products - Update | Morningstar
Earnings from AMD and Pfizer plus labor market data: What to Watch
Pfizer Raises Forecast on Momentum With New Products | Morningstar
Pfizer Appoints Cecile Guegan As CFO
Pfizer Boosts FY26 Outlook - Update
Pfizer Names Cecile Guegan Permanent Chief Financial Officer | Morningstar
Pfizer (PFE) earnings Q3 2026
Pfizer Just Gained 12% in a Month to a 52-Week High: Take Profits, or Buy More?
VCI Wealth Management LLC Purchases 34,235 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Purchased by New England Professional Planning Group Inc.
Promising Healthcare Stocks Worth Watching - November 3rd - Daily Political
Pfizer (NYSE:PFE) Posts Quarterly Earnings Results - Stock Observer
Pfizer Inc. $PFE Holdings Reduced by International Assets Investment Management LLC
Pfizer Inc. $PFE Position Increased by Bank Julius Baer & Co. Ltd Zurich
28,324 Shares in Pfizer Inc. $PFE Purchased by TSG Advice Partners LLC - Stock Observer
Pfizer Inc. $PFE Stock Purchased by New England Professional Planning Group Inc. - Daily Political
Did Cancer Trial Success Just Shift Pfizer (PFE) Investment Narrative?
Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials
Top Dividend Stocks To Watch Now - November 2nd - Markets Daily
Altria vs. Pfizer: Which Dividend Stock Pays You More in 10 Years?
Vise Technologies Inc. Purchases 50,231 Shares of Pfizer Inc. $PFE - Markets Daily
Pfizer Inc. $PFE Stock Acquired by Welch Group LLC
Pfizer Inc. $PFE Shares Sold by Hennessy Advisors Inc.
Pfizer Inc. $PFE Shares Newly Acquired by Mirae Asset Global Investments Co. Ltd.
50,231 Pfizer Inc. $PFE Shares Bought by Vise Technologies Inc. - Stock Observer
PFIZER news
Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors
Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
